TARS

TARS Stock-Based Compensation

$51.81MTTM · USD

Period ending:

TARS FY Stock-Based CompUSD
TARS FY Stock-Based Comp2018-12-31: $9.00K2019-12-31: $18.00K2020-12-31: $839.00K2021-12-31: $8.46M2022-12-31: $13.46M2023-12-31: $19.83M2024-12-31: $27.82M2025-12-31: $41.72M$41.72M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TARS stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Tarsus Pharmaceuticals Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
41,720,000
27,818,000
19,830,000
13,460,000
8,455,000
839,000
18,000
9,000

Compare stock-based compensation

All TARS financial metrics · TARS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.